We are testing a new treatment combining BGB-B3227 with Tislelizumab for patients with advanced or metastatic solid tumors. This study aims to understand how effective this combination may be in treating their condition.
Health conditions and diseases that the clinical trial is designed to study and treat.
Malignant mast cell tumors are a type of cancer that arises from mast cells, which are part of the immune system. These tumors can occur in various organs and may lead to symptoms such as skin rashes, abdominal pain, and anaphylaxis.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.